Psoriasis Clinical Trial
Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With GPP
Summary
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of imsidolimab compared with placebo in adult subjects with generalized pustular psoriasis (GPP).
Full Description
This study will also characterize the pharmacokinetic (PK) profile of imsidolimab and explore the immunogenicity of imsidolimab in subjects with GPP.
Eligibility Criteria
Inclusion Criteria:
-Subject has a BSA affected with pustules (excluding palms and soles) ≥ 5%, a GPPPGA score ≥ 3 (moderate severity), and a PRS score ≥ 3 (moderate severity) at Day 1
Exclusion Criteria:
Subject has other form of psoriasis excluding psoriasis vulgaris
Subject flare is so severe that patient's life is at risk
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 5 Locations for this study
Largo Florida, 33771, United States
Louisville Kentucky, 40056, United States
Ann Arbor Michigan, 48108, United States
Dallas Texas, 75061, United States
Springville Utah, 84663, United States
Melbourne , , Australia
Sydney , , Australia
Batumi , , Georgia
Tbilisi , , Georgia
Tbilisi , , Georgia
Tbilisi , , Georgia
Tbilisi , , Georgia
Bensheim , , Germany
Bonn , , Germany
Hanau , , Germany
Würzburg , , Germany
Pusan , , Korea, Republic of
Seoul , , Korea, Republic of
Seoul , , Korea, Republic of
Seoul , , Korea, Republic of
Cheras , , Malaysia
Johor Bahru , , Malaysia
Kota Bharu , , Malaysia
Kuala Lumpur , , Malaysia
Muar , , Malaysia
Putrajaya , , Malaysia
Casablanca , , Morocco
Casablanca , , Morocco
Oujda , , Morocco
Kraków , , Poland
Ossy , , Poland
Rzeszów , , Poland
Wrocław , , Poland
Łódź , , Poland
Bucuresti , , Romania
Cluj-Napoca , , Romania
Iaşi , , Romania
Svidník , , Slovakia
Barcelona , , Spain
Las Palmas De Gran Canaria , , Spain
Madrid , , Spain
Madrid , , Spain
Valencia , , Spain
Kaohsiung , , Taiwan
Taipei , , Taiwan
Taipei , , Taiwan
Taipei , , Taiwan
Bangkok , , Thailand
Chiang Mai , , Thailand
Khon Kaen , , Thailand
Pathum Thani , , Thailand
Sfax , , Tunisia
Sousse , , Tunisia
Tunis , , Tunisia
Ankara , , Turkey
Antalya , , Turkey
Istanbul , , Turkey
Istanbul , , Turkey
Istanbul , , Turkey
Nilufer , , Turkey
How clear is this clinincal trial information?